Clinical Trial: A Rollover Study of CC-122
Study Status: Completed
Recruit Status: RECRUITING
Condition: Non-Hodgkin Lymphoma
Study Type: INTERVENTIONAL
Official Title: Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating CC-122
Brief Summary:
The purpose of the study is to provide CC-122 treatment to participants who have been receiving treatment in other CC-122 clinical trials investigating CC-122 for more than 5 years (CC-122-ST-001 [NCT01421524], CC-122-ST-002 [NCT02509039], CC-122-DBCL-001 [NCT02031419], and CC-122-NHL-001 [NCT02417285]), receiving clinical benefit from the treatment and to monitor the safety and tolerability of CC-122.
Read more